Pregnant and postpartum women were more severely affected during the second wave of COVID-19 as compared to the first with symptomatic cases and the case fatality rate being significantly higher among this category this year, according to a study by ICMR.
The Indian Council of Medical
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.
There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI
The government Friday said there is no need to panic on the need for an immediate change in the dosage interval of Covishield vaccine, underlining that reducing the time gap requires proper scientific study in the Indian scenario.
In the context of some media reports quoting